biobide

FEBRUARY 2, 2024

Pediatric cancers exhibit differences at the genetic level compared to the same form of adult disease, which may influence the selected treatment. Zebrafish Pioneers Advance in Pediatric Cancer Research and Treatment Increasing the survival rate is the primary goal when screening for cancer drugs.

Disease

The Connected Lab

APRIL 8, 2020

The cost to develop a new prescription medicine that gains market approval has gone up 145% to $2.6 billion and takes an average of 10 years to develop 1. For patients suffering from an illness with no approved treatment, the wait can be unnerving. The drugs used to treat the most common disorders have already been found.

Pharma Companies

H1 Blog

DECEMBER 11, 2024

Drug Policy There will be significant changes in clinical trials & drug development due to the Inflation Reduction Act. As pharmaceutical companies shift their focus toward fewer, high-value therapeutic areas in light of the IRAs drug price negotiations, the overall number of clinical trials will go down.

Clinical Trials

Drug Target Review

MAY 23, 2023

Therapies developed in recent decades have transformed the treatment of IBD, making hospitalisation and surgery less common. However, many patients respond poorly to corticosteroid treatment, or their immune system responds unfavourably to biological therapies, such as the development of autoimmune diseases.

Drugs

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines are novel drug products created to provide improvements for patients that can’t be achieved using traditional therapeutic methods. What is a value-added medicine?

Pharmaceutical Companies

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.

Clinical Trials

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials

Vial

FEBRUARY 19, 2024

I always had the concept of morbidity of medicine and trying to find treatments for patients that are safe and effective and doesn’t have a lot of side effects. We embarked on the development of the next-generation BTK inhibitor, which now is approved called, Calquence. Rich McCormick: Drug development can be quite challenging.

Small Molecule

The Pharma Data

NOVEMBER 10, 2020

Yohan Tessier, Vice President of Commercial Operations & Strategic Development at Mispro, explained that this is critical in expediting their clients’ time to market. We’re seeing a trend in drug development towards super complex and highly-targeted compounds, which requires researchers to conduct a number of preclinical studies.

Marketing

Predictive Oncology

FEBRUARY 7, 2023

With its technology, the company wants to change the way that biopharma companies plan clinical trials and develop oncology drugs. This is all about getting the right drugs to the right patients at the right time as soon as possible to personalize the treatment of their therapies, primarily in oncology,” said Vennare.

Clinical Trials

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Pharma Companies

BioPharma Drive: Drug Pricing

JULY 21, 2025

Clearly, pharma companies will need to leverage considerable contracting power to win a position on payers’ formularies. Complicating factors Manufacturers of biologics and biosimilars alike will be paying close attention to which Stelara biosimilars are able to capture the largest segment of the market—and how they do so.

Biosimilars

The Pharma Data

OCTOBER 20, 2020

When thinking of cancer treatment centers, you likely think of the MD Anderson Cancer Center in Houston, TX. But they know they’re not the only ones out there with innovative ideas for cancer treatment. . MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research.

Clinical Trials

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies

Agency IQ

JULY 12, 2024

The examples : 1) a health care provider posting on the internet about unsubstantiated claims that a class of cholesterol drugs causes Alzheimer’s; 2) a celebrity influencer recommending off-label use (i.e., In fact, a “big pharma” company denying the accuracy of a claim may even serve to legitimize that claim in the eyes of some people.

FDA

The Pharma Data

DECEMBER 30, 2020

It is also being developed for GIST in other treatment settings and has several pipeline compounds for oncology. One of the reasons they expect VC spending in biopharma to expand is that during 2020, particularly from March through about July, many pharma companies, if able, paused their clinical trials.

Vaccine

Drug & Device Law

SEPTEMBER 1, 2023

We observed oral argument the other day in a case that could have a significant impact on potential liability under California tort law for pharma companies and all other innovators. In the end, counsel urged that imposing undue liability would discourage drug development. In Gilead v. Superior Court , No. A165558 (Cal.

Production

Drug Target Review

MARCH 13, 2025

Planning the journey from data to deliverables The future of AI-enabled drug development benefits from the continued advancement of multimodality and clinical genomics, with a focus on integration, efficiency and personalisation to transform both care and R&D. Techbio companies have initiated this approach.

Drug Development